bmy 7378 has been researched along with way 100135 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brightwell, CI; Cliffe, IA; Fletcher, A; Forster, EA; Mansell, HL; Reilly, Y; Routledge, C; White, AC | 1 |
| Dourish, CT; Gurling, J; Routledge, C; Wright, IK | 1 |
2 other study(ies) available for bmy 7378 and way 100135
| Article | Year |
|---|---|
(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.
Topics: Animals; Binding Sites; Piperazines; Rats; Receptors, Serotonin; Serotonin Antagonists; Stereoisomerism; Synapses | 1993 |
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Dopamine; Hippocampus; Injections, Subcutaneous; Male; Microdialysis; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Stereoisomerism | 1993 |